Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cripto | cis | Discovery | rs7610301 | 3:46,646,028 | G/A | 0.24 | 995 | -0.345 | 0.052 | 5.9×10-11 | -1.070 | 3.4×10-7 | 0.023 |
Cripto | cis | Replication | rs6799581 | 3:46,644,909 | A/C | 0.29 | 337 | -0.339 | 0.079 | 2.2×10-5 | -1.070 | 3.9×10-5 | 0.001 |
Target (abbrv.) | Cripto |
Target (full name) | Teratocarcinoma-derived growth factor 1 |
Somalogic ID (Sequence ID) | SL005155 (2672-60_1) |
Entrez Gene Symbol | TDGF1 |
UniProt ID | P13385 |
UniProt Comment |
|
Biomarker applications (based on IPA annotation) |
|
All locus annotations are based on the sentinel SNP (rs7610301) and 19 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Potentially regulated genes | |
eQTL genes |
Trait | P | Study | Source |
---|---|---|---|
Schizophrenia | 3.4×10-5 | 21926974 (PMID) | Supplemental file |
Systemic sclerosis | 5.4×10-5 | 21750679 (PMID) | GRASP2 nonQTL |
Cross-disorder, subset Schizophrenia | 2.4×10-4 | 23453885 (PMID) | Supplemental file |
Serum concentration of 2-hydroxyhippurate (salicylurate) | 2.9×10-4 | 21886157 (PMID) | GRASP2 metabQTL |